Science
Reuters/Dado Ruvic
Britain’s Oxford Vaccine Showing Strong Immune Response in Early Tests
‘ABSOLUTELY DELIGHTED’
Two vaccines—Pfizer-BioNTech and Moderna—have already returned very encouraging preliminary data from their phase three trials.
Trending Now
